Breast Cancer Adjuvant Therapy in Small, Node-Negative HER2+ Early Breast Cancer: ALTTO Sub-Analysis May 23, 2023
Breast Cancer,HER2+ Examining the Potential of Margetuximab in the Treatment of HER2+ Metastatic Breast Cancer May 19, 2023
Breast Cancer,HER2- BioItaLEE Trial: The Role of ctDNA and TKa in HR+, HER2- Advanced Breast Cancer Patients May 19, 2023
Breast Cancer,HER2- QoL in 1L HR+/HER2- ABC Compared: Ribociclib + AI vs. Abemaciclib + AI (MAIC Analysis) May 19, 2023
Breast Cancer,HER2- Palbociclib and Endocrine Therapy for Metastatic Breast Cancer Patients May 19, 2023
Breast Cancer,Other Cancers Ribociclib vs Abemaciclib: Quality of Life in HR+/HER2- Advanced Breast Cancer May 16, 2023
